With this in mind, the recent VANISH trial [4] sought to determine whether AVP in higher than previously used doses (up to 0.06 U/min) would improve renal outcomes compared with norepinephrine.

Studies that have evaluated the use of intravenous vitamin C in adults with sepsis who were receiving vasopressor therapy in the intensive care unit (ICU) have shown mixed results with respect to the ...

SAN FRANCISCO -- For sepsis-induced hypotension, a restrictive fluid strategy with earlier vasopressor use didn't impact mortality compared with liberal fluids, the CLOVERS trial showed. The ...

Sepsis is the body’s extreme reaction to an infection. It causes 11 million deaths annually and is a global health priority affecting 55 million patients worldwide annually. Treatment for sepsis ...